The Trump administration’s foreign aid freeze halted major malaria vaccine research. The USAID Malaria Vaccine Development Program (MVDP) told partners to stop work immediately. The freeze disrupts collaboration between U.S. and international researchers.
Affected teams included experts from Johns Hopkins University and the University of Oxford. The program aimed to reduce child deaths by developing improved malaria vaccines.
The funding freeze also halted medicine shipments and raised global health concerns. Malaria kills about 450,000 children under five in Sub-Saharan Africa each year.